Apatinib Combined With S-1 in the Second-line Treatment of Advanced Pancreatic Cancer
Clinical trial NCT03662035 · UNKNOWN
Trial details
- NCT number
- NCT03662035
- Sponsor
- Changzhou No.2 People's Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-15
- Primary completion
- 2020-03-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.